Literature DB >> 16962248

Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia.

Marco Bonifazi1, Anna Lisa Suman, Caterina Cambiaggi, Andrea Felici, Giovanni Grasso, Leda Lodi, Marzia Mencarelli, Michela Muscettola, Giancarlo Carli.   

Abstract

The aim of the present study was to investigate the effects of a 3-week residential multidisciplinary non-pharmacological treatment program (including individually prescribed aerobic exercise and cognitive-behavioral therapy) on fibromyalgia symptoms and hypothalamic-pituitary-adrenal (HPA) axis function. Salivary and venous blood samples were collected from 12 female patients with fibromyalgia (age: 25-58) the day before and the day after the treatment period: saliva, eight times (every two hours from 0800 to 2200 h); venous blood, at 0800 h. Peripheral blood mononuclear cells (PBMC) were separated and analyzed for glucocorticoid receptor-alpha (GR-alpha) mRNA expression by semi-quantitative RT-PCR, while the salivary cortisol concentration was determined by RIA. At the same time, pain and aerobic capacity were evaluated. Aerobic capacity improved at the end of the treatment program. The slope of the regression of salivary cortisol values on sampling time was steeper in all patients after treatment, indicating that the cortisol decline was more rapid. Concomitantly, the area under the cortisol curve "with respect to increase" (AUC(i)) was higher and there was a significant increase in GR-alpha mRNA expression in PBMC. The number of positive tender points, present pain, pain area and CES-D score were significantly reduced after the treatment, while the pressure pain threshold increased at most of the tender points. Our findings suggest that one of the active mechanisms underlying the effects of our treatment is an improvement of HPA axis function, consisting in increased resiliency and sensitivity of the stress system probably related to stimulation of GR-alpha synthesis by the components of the treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962248     DOI: 10.1016/j.psyneuen.2006.06.008

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  11 in total

1.  [Back pain. Many questions and still too few answers].

Authors:  M Zenz
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

Review 2.  Effects of experimental housing conditions on recovery of laboratory mice.

Authors:  Paulin Jirkof
Journal:  Lab Anim (NY)       Date:  2015-02       Impact factor: 12.625

3.  Salivary cortisol and cold pain sensitivity in female twins.

Authors:  Kathryn M Godfrey; Eric Strachan; Elizabeth Dansie; Leslie J Crofford; Dedra Buchwald; Jack Goldberg; Brian Poeschla; Annemarie Succop; Carolyn Noonan; Niloofar Afari
Journal:  Ann Behav Med       Date:  2014-04

Review 4.  Duloxetine for the treatment of fibromyalgia.

Authors:  Cheryl L Wright; Scott D Mist; Rebecca L Ross; Kim D Jones
Journal:  Expert Rev Clin Immunol       Date:  2010-09       Impact factor: 4.473

5.  Pain catastrophizing and salivary cortisol responses to laboratory pain testing in temporomandibular disorder and healthy participants.

Authors:  Phillip J Quartana; Luis F Buenaver; Robert R Edwards; Brendan Klick; Jennifer A Haythornthwaite; Michael T Smith
Journal:  J Pain       Date:  2009-10-22       Impact factor: 5.820

6.  An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia.

Authors:  Kathryn Curtis; Anna Osadchuk; Joel Katz
Journal:  J Pain Res       Date:  2011-07-26       Impact factor: 3.133

7.  Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: does the time from hysterectomy provide a clue?

Authors:  Larry Brooks; Joseph Hadi; Kyle T Amber; Michelle Weiner; Christopher L La Riche; Tamar Ference
Journal:  J Pain Res       Date:  2015-08-20       Impact factor: 3.133

8.  Individual variation in diurnal cortisol in patients with knee osteoarthritis: Clinical correlates.

Authors:  Myrella Paschali; Asimina Lazaridou; Theodoros Paschalis; Julia R Moradian; Jason Sadora; Eric S Vilsmark; Robert R Edwards
Journal:  Int J Psychophysiol       Date:  2021-06-15       Impact factor: 2.903

9.  A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study.

Authors:  Juliane Hellhammer; Dominic Vogt; Nadin Franz; Ulla Freitas; David Rutenberg
Journal:  Lipids Health Dis       Date:  2014-07-31       Impact factor: 3.876

10.  Secondary Adrenal Insufficiency and Growth Hormone Deficiency in Patients with Fibromyalgia.

Authors:  Lucinda M Gruber; Sanjeev Nanda; Todd Nippoldt; Alice Y Chang; Irina Bancos
Journal:  J Pain Res       Date:  2021-05-19       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.